A new era in stroke prevention for atrial fibrillation: comment on "current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation.
Division of General Medicine, Massachusetts General Hospital, Boston (Dr Singer); and Division of Research, Kaiser Permanente Northern California, Oakland (Dr Go).Archives of internal medicine (Impact Factor: 11.46). 04/2012; 172(8):631-3. DOI:10.1001/archinternmed.2012.897
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.